Form 6-K BioNTech SE For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
BioNTech (BNTX) PT Raised to $126 at BMO Capital
November 4, 2024 4:06 PM ESTBMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a Outperform rating.
The analyst comments "BNTX announced revenues of 1.24B, above FactSet consensus (+142%) and reiterated FY24 guidance of 2.5-3.1B in revenues,... More
BofA Securities Reiterates Buy Rating on BioNTech (BNTX)
November 4, 2024 12:47 PM ESTBofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $150.00 price target on BioNTech (NASDAQ: BNTX).
The analyst comments "BioNTech (BNTX) reported 1.2bn in 3Q COVID revenues ahead of our and consensus 362mn estimates. The company noted this was mainly driven by earlier global... More
